measuregroup/AID1797863

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID378162168_AID1797863_PMID_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID386401355_AID1797863_PMID_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID386401356_AID1797863_PMID_VALUE7 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID386401362_AID1797863_PMID_VALUE8 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID386401348_AID1797863_PMID_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID386401349_AID1797863_PMID_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID386401348_AID1797863_PMID_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID386401356_AID1797863_PMID_VALUE6
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ12809
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	hERG Channel Inhibition from US Patent US10221182: \"3,3-difluoro-piperidine derivatives as NR2B NMDA receptor antagonists\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID386401362 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID386401348 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID378162168 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID386401349 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID386401356 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID386401355
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1797863

Total number of triples: 19.